AzTrials
AzTrials

Anxiety DisorderNCT01453452

S1008: Exercise, Diet, & Counseling in Improving Weight Loss in Overweight Female Breast or Colorectal Cancer Survivors

A study testing behavioral dietary intervention, exercise intervention and counseling intervention in people with Anxiety Disorder and Breast Cancer, run by SWOG Cancer Research Network at 58 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

RATIONALE: Physical activity, diet, and counseling may help breast and colorectal cancer survivors to lose weight and improve their quality of life. PURPOSE: This phase II trial studies how well exercise, diet, and counseling work in improving physical activity and weight loss in overweight women who are breast and… Read more about this study

Who is it for?
Ages Up to 120 years, women only
What is being tested?
behavioral dietary intervention, exercise intervention and counseling intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
58 sitesUnited States
Study dates
Mar 2012to Jan 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 120 years
  • Women only
  • No healthy volunteers
  • Child, Adult, Older adult

DISEASE CHARACTERISTICS:

  • Participants must be women with a previous diagnosis of stage I, II, or III invasive breast cancer or colorectal cancer
  • Participants must have no evidence of disease at the time of registration and no history of metastases (M0)
  • Participants must have a body mass index ≥ 25 kg/m^2 measured within 28 days of registration
  • Participants must be considered sedentary (defined as < 60 minutes of moderate to vigorous physical activity per week; moderate exercise defined as exercising to the point of sweating)
  • Participants must be willing to submit blood samples for biomarkers (insulin, glucose, HgbA1C, estradiol, and testosterone) and undergo DXA scans, and must be given the option to consent for specimen submission for banking and future translational medicine studies
  • Participants must be willing and able to attend a Curves fitness center at least 3 times per week for 12 months

PATIENT CHARACTERISTICS:

  • Participants must be post-menopausal, as defined by at least one of the following:
  • At least 12 months since the last menstrual period
  • Prior bilateral oophorectomy
  • Previous hysterectomy with one or both ovaries left in place (or previous hysterectomy in which documentation of bilateral oophorectomy is unavailable) AND follicle-stimulating hormone (FSH) values consistent with the institutional normal values for the post-menopausal state
  • If participant is under the age of 55, FSH levels must be obtained within 28 days prior to registration
  • Zubrod performance status of 0
  • Participants must have no abnormal changes on a regular (non-nuclear) cardiovascular exercise stress test (using a treadmill or bicycle) as measured by electrocardiogram (EKG)
  • EKG must be within institutional limits of normal
  • Results of previous cardiac exercise stress test may be used as long as it was done within 3 months prior to registration
  • Participants must not have evidence of uncontrolled hypertension
  • Participants with diabetes, pre-diabetes, and/or metabolic syndrome must have HgbA1C ≤ 8% within the past 28 days
  • Current use of diabetes medications is allowed
  • No other prior malignancy is allowed except for adequately treated basal cell or squamous cell skin cancer, in situ cervical cancer, or other cancer for which the participant has been disease-free for > 5 years
  • Participants must not be active smokers within past 90 days; active smoking is defined as any smoking, even a puff
  • Participants must have regular access to the internet in order to receive monthly nutrition-program newsletter e-mails and to complete study questionnaires online
  • Participants must be able to understand, speak, and read English
  • Participants must have a home phone or cell phone and agree to participate in the 14 (40-minute) behavioral counseling sessions and 9 (20-30-minute) telephone interviews
  • Participants must have a baseline physical exam and physician clearance (primary care provider, medical oncologist, or surgical oncologist) to participate in the weight loss and exercise prior to enrollment within 60 days of registration; copy of physician clearance document must be submitted

PRIOR CONCURRENT THERAPY:

  • Participants must be 90 days to 730 days post-surgery, chemotherapy, and radiation therapy
  • Current hormonal therapy is allowed among breast cancer participants
  • Other concurrent anti-cancer therapies, including Herceptin, are not allowed
  • Surgery is defined as any major surgical procedure (resection or reconstructive) that would preclude inclusion in the exercise program
  • If the participant has had a remedial surgical procedure (e.g., revision of reconstruction) or persistent complications from her original operation, approval will be obtained from the participant's surgeon prior to enrollment
  • Persistent complications may include, but are not limited to, prolonged wound healing, hernias, or ostomy prolapse

Trial locations and contacts

58 sites in 1 country.

58 sites in 1 country

United States58 sites
  • Kaiser Permanente-Deer Valley Medical Center

    Antioch, California, 94531

  • Cancer Center of Kansas - Chanute

    Chanute, Kansas, 66720

  • Cancer Center of Kansas - Dodge City

    Dodge City, Kansas, 67801

  • Swedish Medical Center-Edmonds

    Edmonds, Washington, 98026

  • Cancer Center of Kansas - Fort Scott

    Fort Scott, Kansas, 66701

  • Kaiser Permanente, Fremont

    Fremont, California, 94538

  • Kaiser Permanente

    Fresno, California, 93720

  • Cancer Centers of the Carolinas - Faris

    Greenville, South Carolina, 29605

  • Cancer Centers of the Carolinas - Grove Commons

    Greenville, South Carolina, 29605

  • Greenville Memorial Hospital

    Greenville, South Carolina, 29605

  • Greenville CCOP

    Greenville, South Carolina, 29615

  • Cancer Centers of the Carolinas-Greer Medical Oncology

    Greer, South Carolina, 29650

  • Kaiser Permanente, Hayward

    Hayward, California, 94545

  • Kaiser Permanente Moanalua Medical Center

    Honolulu, Hawaii, 96819

  • Cancer Center of Kansas-Independence

    Independence, Kansas, 67301

  • University of Kansas Medical Center

    Kansas City, Kansas, 66160

  • Cancer Center of Kansas-Kingman

    Kingman, Kansas, 67068

  • Lawrence Memorial Hospital

    Lawrence, Kansas, 66044

  • Cancer Center of Kansas-Liberal

    Liberal, Kansas, 67901

  • Loyola University Medical Center

    Maywood, Illinois, 60153

  • Kaiser Permanente-Modesto

    Modesto, California, 95356

  • Columbia University Medical Center

    New York, New York, 10032

  • Cancer Center of Kansas - Newton

    Newton, Kansas, 67114

  • Kaiser Permanente-Oakland

    Oakland, California, 94611

  • Cancer Center of Kansas - Parsons

    Parsons, Kansas, 67357

  • Cancer Center of Kansas - Pratt

    Pratt, Kansas, 67124

  • Kaiser Permanente-Redwood City

    Redwood City, California, 94063

  • Kaiser Permanente-Richmond

    Richmond, California, 94801

  • Kaiser Permanente-Roseville

    Roseville, California, 95661

  • William Beaumont Hospital

    Royal Oak, Michigan, 48073

  • Kaiser Permanente-South Sacramento

    Sacramento, California, 95823

  • Kaiser Permanente - Sacramento

    Sacramento, California, 95825

  • Cancer Center of Kansas - Salina

    Salina, Kansas, 67401

  • Southwest Oncology Group

    San Antonio, Texas, 78245

  • Kaiser Permanente-San Francisco

    San Francisco, California, 94115

  • Kaiser Permanente-Santa Teresa-San Jose

    San Jose, California, 95119

  • Kaiser Permanente-San Rafael

    San Rafael, California, 94903

  • Kaiser Permanente Medical Center - Santa Clara

    Santa Clara, California, 95051

  • Kaiser Permanente-Santa Rosa

    Santa Rosa, California, 95403

  • Swedish Medical Center-First Hill

    Seattle, Washington, 98122-4307

  • University of Washington Medical Center

    Seattle, Washington, 98195

  • Cancer Centers of the Carolinas - Seneca

    Seneca, South Carolina, 29672

  • Kaiser Permanente-South San Francisco

    South San Francisco, California, 94080

  • Cancer Centers of the Carolinas - Spartanburg

    Spartanburg, South Carolina, 29307

  • Kaiser Permanente-Stockton

    Stockton, California, 95210

  • William Beaumont Hospital - Troy

    Troy, Michigan, 48098

  • Arizona Cancer Center at University Medical Center North

    Tucson, Arizona, 85719

  • University of Arizona Health Sciences Center

    Tucson, Arizona, 85724

  • Kaiser Permanente Medical Center-Vacaville

    Vacaville, California, 95688

  • Kaiser Permanente-Vallejo

    Vallejo, California, 94589

  • Kaiser Permanente-Walnut Creek

    Walnut Creek, California, 94596

  • Cancer Center of Kansas - Wellington

    Wellington, Kansas, 67152

  • Associates In Womens Health

    Wichita, Kansas, 67208

  • Cancer Center of Kansas-Wichita Medical Arts Tower

    Wichita, Kansas, 67208

  • Cancer Center of Kansas - Main Office

    Wichita, Kansas, 67214

  • Via Christi Regional Medical Center

    Wichita, Kansas, 67214

  • Wichita CCOP

    Wichita, Kansas, 67214

  • Cancer Center of Kansas - Winfield

    Winfield, Kansas, 67156

Other trials in United States

About this study

Official title: S1008: Feasibility Study of a Physical Activity and Dietary Change Weight Loss Intervention In Breast and Colorectal Cancer Survivors, Phase II

RATIONALE: Physical activity, diet, and counseling may help breast and colorectal cancer survivors to lose weight and improve their quality of life.

PURPOSE: This phase II trial studies how well exercise, diet, and counseling work in improving physical activity and weight loss in overweight women who are breast and colorectal cancer survivors.

Read the detailed description

OBJECTIVES:

Primary

  • To determine the feasibility of a 12-month community-based combined physical activity and dietary change weight-loss intervention in overweight and sedentary female breast and colorectal cancer survivors recruited via the Southwest Oncology Group (SWOG).
  • To estimate the effect size of the intervention on weight loss at 12 months.

Secondary

  • To measure changes in anthropometric measures from baseline (body mass index [BMI], waist and hip circumference) at 6 and 12 months and body composition (% body fat as assessed by dual-energy X-ray absorptiometry [DXA] scan) at 12 months.
  • To measure changes in minutes spent per week in moderate-to-vigorous aerobic activity from baseline using Curves attendance records and a 7-day physical activity assessment at 6 and 12 months.
  • To measure changes from baseline to 6 and 12 months in dietary intake of carotenoids via serum carotenoid measures.
  • To assess changes from baseline to 6 and 12 months in perceived benefit of dietary change, physical activity, and weight loss after a cancer diagnosis.
  • To measure changes from baseline in metabolic and hormonal biomarkers associated with breast and colorectal cancer recurrence risk (fasting insulin, fasting glucose, hemoglobin A1C, bioavailable estradiol, free testosterone, and adiponectin) at 6 and 12 months.
  • To assess changes from baseline in anxiety, depression, fatigue, sleep, satisfaction with social roles, pain, and physical function using the PROMISE-43 at 6 and 12 months.
  • To assess baseline predictors (medical history, health behaviors, quality of life) of subjects who adhere to and complete the intervention.
  • To assess the diversity of subjects who enroll and complete the intervention.
  • To assess the availability and acceptability of the Curves fitness centers at 12 months.
  • To explore changes in DNA methylation.
  • To assess the intervention and study process via open-ended interviews with SWOG sites and Curves franchises.
  • To measure changes in anthropometric measures and assess feasibility of extended follow-up at 24 and 36 months.
  • To assess the safety of the Curves® fitness centers for this population by assessing self-reported changes in lymphedema and any injuries as measured at 6 and 12 months.

OUTLINE: Participants are stratified according to type of cancer (breast vs colorectal).

Participants are instructed to practice 30-45 minutes of medium-to-hard exercise 5-7 days a week at a Curves fitness center (paid by study) or outside Curves for 12 months. Participants receive written materials on physical activity guidelines for survivors and a pedometer to track their physical activity outside Curves. They also receive the Curves Fitness \& Weight Management Plan and are instructed to follow a "higher carbohydrate" diet plan, which promotes a 1,500 kcal/day diet that is high in fruit and vegetables consisting of 30% protein, 45% carbohydrates, and 25% fat. In addition, participants receive the dietary guidelines for cancer survivors, which recommend eating 5 or more servings of fruit/vegetables per day, a diet high in whole grains, low in saturated fat, low in sugary foods, and low in alcohol. Participants receive 14 behavioral-counseling sessions by telephone with the goal to increase intervention adherence and participation retention. Each session lasts 40 minutes and occurs weekly on weeks 1-5 and then every 6 weeks by month 6. Participants receive monthly email newsletters with health tips and motivational messages to encourage adherence and retention to the study program. Counselors also conduct three 24-hour dietary recall assessments and 1 physical activity assessment at 6 and 12 months.

Participants complete a PROMIS-43 quality-of-life questionnaire at 6 and 12 months via internet, mail, or telephone.

Participants also undergo blood sample collection at baseline and at 6 and 12 months for fasting glucose and insulin tests, and biomarker studies. Anthropometric measurements (height, weight, waist, and hip circumference) are also collected.

After completion of study intervention, participants are followed up at 24 and 36 months.

Being tested
behavioral dietary intervention, exercise intervention, counseling intervention, quality-of-life assessment
Keywords
weight changes, fatigue, depression, anxiety disorder, pain, cognitive/functional effects, psychosocial effects of cancer and its treatment, cancer survivor, stage IA breast cancer, stage IB breast cancer, stage II breast cancer, stage IIIA breast cancer, stage IIIB breast cancer, stage IIIC breast cancer, stage I colon cancer, stage IIA colon cancer, stage IIB colon cancer, stage IIC colon cancer, stage IIIA colon cancer, stage IIIB colon cancer
Medical subject headings
Anxiety Disorders, Breast Neoplasms, Colorectal Neoplasms, Depression, Fatigue, Pain, Body Weight Changes, Colonic Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • behavioral dietary interventionBehavioural

    Reduce caloric intake by 500 kcal/day, increase fruit and vegetable intake to 5 or more servings per day, and limit daily calories from fat to be < 30%. Diet will be measured using 3 repeated 24-hr diet recalls. Participants will receive information on the recommended dietary modifications via mailed materials and telephone counseling sessions.

  • exercise interventionBehavioural

    150 min/wk of moderate exercise through use of the Curves® centers, engage in physical activity outside of Curves®, and use pedometers to track activity.

  • counseling interventionOther

    14 40-min behavioral counseling sessions via telephone with the goal of increasing intervention adherence and increasing participant retention.

  • quality-of-life assessmentProcedure or surgery

    PROMIS-43 - online questionnaire to assess quality of life.

Study groups in NCT01453452
Study groupRoleWhat they receive
Exercise and Lifestyle counselingExperimentalPatients will receive behavioral dietary intervention \& counseling intervention by phone, exercise intervention at Curves(R) facility, and take a quality-of-life assessment online.
Receives: Behavioral: behavioral dietary intervention; Behavioral: exercise intervention; Other: counseling intervention; Procedure: quality-of-life assessment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Attendance of ≥ 2 Curves sessions/week for a minimum of 36 of the 52 weeks of intervention

    Measured: 1 year from registration

  2. Increase in fruit and vegetable consumption by 1 full serving per day (not including iceberg lettuce, potatoes, or fruit juices) OR reduce caloric intake by 100 kcal/day

    Measured: 1 year from registration

Secondary outcomes (7)
  1. Changes in anthropometric measures (weight, BMI, waist circumference, hip circumference)

    Measured: 1 year from registration

  2. Changes in body composition (% body fat as assessed by DXA scan at 12 months only)

    Measured: 1 year from registration

  3. Changes in minutes spent per week in moderate-to-vigorous intensity aerobic activity using Curves attendance records and a 7-day physical activity recall assessment

    Measured: 1 year from registration

  4. Changes in dietary intake patterns based on three separate 24-hour diet recalls

    Measured: 1 year from registration

  5. Changes in metabolic and hormonal biomarkers associated with breast and colorectal cancer-recurrence risk (fasting insulin, fasting glucose, hemoglobin A1C, bioavailable estradiol, free testosterone, and adiponectin)

    Measured: 3 years

  6. Changes in anxiety, depression, fatigue, sleep, satisfaction with social roles, pain, and physical function as measured by the PROMIS-43

    Measured: 1 year from registration

  7. DNA methylation patterns

    Measured: 3 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Oct 2011 (estimated)
  2. Study startMar 2012
  3. Primary completionAug 2015
  4. Study completionJan 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
50 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01453452
Sponsor's protocol ID
S1008
Other IDs
S1008, U10CA037429, NCI-2011-03539
Status last verified
Jan 2020
First submitted
14 Oct 2011
Last updated
18 Jan 2020
Results posted
No
Data monitoring committee
Yes

Publications

  • Greenlee H, Lew DL, Hershman DL, Newman VA, Hansen L, Hartman SJ, Korner J, Shi Z, Sardo Molmenti CL, Sayegh A, Fehrenbacher L, Lo S, Klemp J, Rinn K, Robertson JM, Unger J, Gralow J, Albain K, Krouse R, Fabian C. Phase II Feasibility Study of a Weight Loss Intervention in Female Breast and Colorectal Cancer Survivors (SWOG S1008). Obesity (Silver Spring). 2018 Oct;26(10):1539-1549. doi: 10.1002/oby.22269. Epub 2018 Sep 11.

    PubMed 30272836

Questions about this trial

What is this clinical trial studying?

A study testing behavioral dietary intervention, exercise intervention and counseling intervention in people with Anxiety Disorder and Breast Cancer, run by SWOG Cancer Research Network at 58 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Jan 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 58 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Attendance of ≥ 2 Curves sessions/week for a minimum of 36 of the 52 weeks of intervention (time frame: 1 year from registration). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01453452, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jan 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in